Streetbeat News

Products Services

MRNA

Moderna, Inc. (NASDAQ:MRNA) has announced regulatory submissions for its Respiratory Syncytial Virus (RSV) vaccine, mRNA-1345, aimed at preventing RSV-associated lower respiratory tract disease and acute respiratory disease in adults aged 60 years or older. The company has submitted marketing authorization applications to the European Medicines Agency, Swissmedic, and the Therapeutic Goods Administration in Australia, and initiated the rolling submission process for a Biologics License Application to the U.S. FDA.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 11:02 am

AMZN

Amazon.com Inc. has announced the Amazon Prime Day 2023 sale for July 11 and 12, offering discounts on a wide range of products. The company has provided tips on how to prepare for the sale, including becoming an Amazon Prime member, scoring free Amazon credit, updating payment methods, signing up for invite-only deals, and setting up deal alerts.

Portfolio Pulse from Rounak Jain

July 05, 2023 | 10:49 am

INCY

The Medicines and Healthcare Products Regulatory Agency has approved Incyte Biosciences' Opzelura (Ruxolitinib) cream for non-segmental vitiligo with facial involvement in patients aged 12 years and above.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 10:16 am

FXI

MRNA

Moderna has signed a Memorandum of Understanding (MoU) and a collaboration agreement to research, develop, and manufacture mRNA medicines in China. The medicines produced under this agreement will be exclusively for the Chinese people and will not be exported.

Portfolio Pulse from Charles Gross

July 05, 2023 | 10:09 am

EWJ

TSLA

Tesla has reduced the prices of its Model 3 and Model Y in Japan by approximately 3% and 4% respectively, according to Reuters.

Portfolio Pulse from Charles Gross

July 05, 2023 | 10:07 am

IMPL

Impel Pharmaceuticals has received a US patent for respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for Parkinson's disease, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 9:54 am

AXTI

FXI

AXT's subsidiary in China, Tongmei, plans to immediately seek permits from Chinese authorities to export gallium and germanium substrate products. This news has led to a 7.7% premarket increase in AXT shares.

Portfolio Pulse from Charles Gross

July 05, 2023 | 9:52 am

AMRX

Amneal Pharmaceuticals has received a Complete Response Letter from the FDA regarding its New Drug Application for IPX203, a treatment for Parkinson's disease.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 9:52 am

AAPL

MSFT

Apple Inc. has updated its Game Porting Toolkit, which is designed to enhance the performance of Windows games running on a Mac. The update has led to noticeable performance improvements in various games and resolved stability issues. However, the toolkit is primarily a tool for developers and not a consumer gaming product.

Portfolio Pulse from Sudhanshu Singh

July 05, 2023 | 9:45 am

FSR

Fisker Inc (NYSE:FSR) CEO Henrik Fisker teased the company's third vehicle, Ronin, on Instagram. The all-electric sport grand tourer vehicle, which can accommodate 5 people and has an anticipated range of 600 miles, will be revealed on Aug. 3. The Ronin project was announced in May 2022 and is expected to start production in the second half of 2024. Fisker delivered its first Ocean SUV in May and began US deliveries last month. The delivery timeline for its second vehicle, Pear, has been delayed to 2025.

Portfolio Pulse from Anan Ashraf

July 05, 2023 | 9:25 am